Table 1.
Histopathological scoring findings of experimental groups ( Healthy, I (Ischemia),I+ASX 50, I+ASX100, I/R (Ischemia and Reperfusion), I/R+ ASX 50, and I/R+ ASX100)
| Groups | Hemorrhage | Edema | Necrotic cells |
Inflammatory cells |
|---|---|---|---|---|
| Healthy | - | - | - | - |
| Ischemia | +++ | ++ | ++ | - |
| I+ASX50 | ++ | - | - | - |
| I+ASX100 | + | - | - | - |
| I/R | + | + | + | + |
| I/R+ASX50 | -/+ | - | - | - |
| I/R+ASX100 | - | - | - | - |
Note: histopathological scoring was performed considering the hemorrhagic and edematous areas observed in the ovary, presence of necrotic cells, and accumulation of inflammatory cells; symbolized to be absent (-), mild (+), moderate (++), and severe (+++) damage